UNIVERSITY OF NORTH CAROLINA HOSPITALS
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1989-01-01
- Employees
- -
- Market Cap
- -
High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
Phase 2
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2004-07-22
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 61
- Registration Number
- NCT00003392
- Locations
- 🇺🇸
Scripps Clinic, La Jolla, California, United States
🇺🇸University of California San Diego, La Jolla, California, United States
🇺🇸Walter Reed Army Medical Center, Washington, District of Columbia, United States
Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer
Phase 1
Withdrawn
- Conditions
- Prostate Cancer
- First Posted Date
- 2004-04-20
- Last Posted Date
- 2012-04-24
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Registration Number
- NCT00005827
- Locations
- 🇺🇸
Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States
Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Phase 1
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2004-02-26
- Last Posted Date
- 2012-02-07
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Registration Number
- NCT00006108
- Locations
- 🇺🇸
Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States
Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy
Phase 2
Terminated
- Conditions
- Prostate Cancer
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2012-05-23
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 37
- Registration Number
- NCT00073970
- Locations
- 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer
Phase 2
Completed
- Conditions
- Breast Cancer
- Interventions
- Biological: trastuzumabProcedure: conventional surgery
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2017-07-31
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 82
- Registration Number
- NCT00006110
- Locations
- 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States